Development of treatments for sarcopenia: new challenges, opportunities and perspectives

Leo Westbury, Elizabeth M. Curtis, Ewa Balkowiec-Iskra, Antonio Cherubini, Mario Miguel Coelho da Silva Rosa, Paolo Foggi, Yury Kiselev, Andrea Laslop, Sif Ormarsdóttir, Maria Concepcion Prieto Yerro, Carla Torre, Katarina Vucic, Majed Alokail, Ali Al-Samil, Gulistan Bahat, Mario Barbagallo, Jürgen M. Bauer, Charlotte Beaudart, Angie Botto-van Bemden, Olivier Bruyère, Nansa Burlet, Etienne Cavalier, Alfonso J. Cruz-Jentoft, Patrizia D’Amelio, Sandra De Breucker, Gustavo Duque, Roger A. Fielding,
Nature Reviews Rheumatology · Springer Nature · 2026-11-16 · DOI: 10.1038/s41584-026-01457-4

Abstract

Nature Reviews Rheumatology, Published online: 16 November 2026; doi:10.1038/s41584-026-01457-4 This Perspective presents contemporary perspectives on advances and challenges in the development of pharmacological interventions for sarcopenia, including discussion of the evolving definition of sarcopenia, the changing regulatory landscape and considerations for the design of clinical trials.

Read at publisher →

Similar articles